LeMaitre Vascular, Inc.LMATNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank86
3Y CAGR+2.1%
5Y CAGR+7.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+2.1%/yr
vs +12.8%/yr prior
5Y CAGR
+7.0%/yr
Recent deceleration
Acceleration
-10.8pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$14.14M-9.7%
2024$15.65M-7.8%
2023$16.97M+27.6%
2022$13.29M+12.7%
2021$11.80M+16.9%
2020$10.10M+8.9%
2019$9.28M+13.2%
2018$8.20M+23.5%
2017$6.64M+8.1%
2016$6.14M-